Title of article
Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA
Author/Authors
D. Stejskal، نويسنده , , M. Karp??ek، نويسنده , , H. Reutov?، نويسنده , , P. Stejskal، نويسنده , , H. Kotolov?، نويسنده , , Peter Koll?r، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
4
From page
313
To page
316
Abstract
Objectives
To develop an assay for the determination of ZAG in human serum, and to investigate its clinical relevance as a marker of metabolic syndrome.
Design and methods
A new sandwich ELISA was introduced and clinically tested.
Results
ZAG serum level did not differentiate healthy subjects (27.4 ± 8.3 mg/L; N = 132) from patients with metabolic syndrome (24.9 ± 8.1; N = 92). ZAG correlated with glucose, creatinine and uric acid.
Conclusion
The immunoassay offers a new research tool for glucose metabolism.
Keywords
obesity , ELISA , metabolic syndrome , Zinc-alpha-2-glycoprotein
Journal title
Clinical Biochemistry
Serial Year
2008
Journal title
Clinical Biochemistry
Record number
485143
Link To Document